Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

0.7542
+0.01421.92%
Post-market: 0.75420.00000.00%17:33 EDT
Volume:35.94K
Turnover:27.62K
Market Cap:42.16M
PE:-0.59
High:0.7860
Open:0.7400
Low:0.7400
Close:0.7400
Loading ...

Q4 2024 Spero Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Mar

Spero Therapeutics Inc (SPRO) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges ...

GuruFocus.com
·
28 Mar

Spero Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

BRIEF-Spero Therapeutics Q4 EPS USD -0.38

Reuters
·
28 Mar

Spero Therapeutics:Existing Cash,Together With Earned Development Milestones From GSK, Provide Runway to Fund Operating Expenses & Capex Into Q2 2026

THOMSON REUTERS
·
28 Mar

Spero Therapeutics Q4 EPS USD -0.38

THOMSON REUTERS
·
28 Mar

Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

GlobeNewswire
·
18 Mar

Spero Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
14 Mar

Spero Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
07 Mar

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

Zacks
·
16 Jan

Spero Therapeutics announces interim leadership changes

TIPRANKS
·
10 Jan

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

THOMSON REUTERS
·
10 Jan

Spero Therapeutics Inc - Leadership Changes Follow Response to a SEC Wells Notice Relating to Certain Public Disclosures Made in 2022

THOMSON REUTERS
·
10 Jan

Spero Therapeutics Inc - Frank Thomas Appointed Chairman of the Board

THOMSON REUTERS
·
10 Jan

Spero Therapeutics Inc - Cash Runway Guidance Remains Into Mid-2026

THOMSON REUTERS
·
10 Jan

Spero Therapeutics Inc - Esther Rajavelu Appointed Interim President and CEO

THOMSON REUTERS
·
10 Jan

Spero Therapeutics Inc - Sath Shukla on Voluntary Paid Administrative Leave for Interim Period

THOMSON REUTERS
·
10 Jan

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

Zacks
·
04 Jan

MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug

Zacks
·
03 Jan

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Zacks
·
03 Jan